[Clinical experience with cefodizime in pediatric field]

Area of Science:

• Pediatric infectious diseases
• Bacteriology
• Pharmacology

Context:

• Acute bacterial infections in children require effective and safe antibiotic treatments.
• Cefodizime (CDZM) is an antibiotic investigated for pediatric use.
• Previous research may not have fully established CDZM's efficacy and safety in diverse pediatric bacterial infections.

Purpose:

• To evaluate the clinical efficacy and safety of intravenous Cefodizime (CDZM) in pediatric patients with acute bacterial infections.
• To assess the bacteriological eradication rates of identified pathogens following CDZM treatment.
• To determine the incidence of adverse effects associated with CDZM administration in children.

Summary:

• Intravenous Cefodizime (CDZM) was administered to 20 children diagnosed with acute bacterial infections, including tonsillitis, bronchitis, purulent cervical lymphadenitis, urinary tract infections, and pneumonia.
• Clinical efficacy was observed in 18 out of 20 patients (90%), with complete eradication of all 5 identified bacterial strains.
• One case of eosinophilia was the only reported side effect, indicating a generally good safety profile.

Impact:

• Cefodizime (CDZM) shows significant promise as a safe and effective antibiotic for treating a range of bacterial infections in pediatric populations.
• The findings support the use of CDZM in clinical practice for pediatric infectious disease management.
• Further research could explore CDZM's role in specific pediatric infection subtypes and long-term outcomes.